Healthcare and Medical
Healthcare and Medical
home | healthcare and medical | company profile
Premium Company Profile - Celgene (Datamonitor)
- Market: Healthcare and Medical
- Published Date: 24/10/2007
- Report Title: Premium Company Profile - Celgene
- Table of Contents: View Table of Contents
- Report Type: Company Profile
- Country: Global
- Number of Pages: 58
Introduction
Celgene is engaged in the discovery, development, and commercialization of therapies for the treatment of cancer and immunological diseases. Among seven marketed products, the company's lead product is Revlimid, an analog of thalidomide that is approved by the FDA for the treatment of MDS patients with the 5q chromosomal deletion and for the treatment of relapsed/refractory myeloma.
Scope
Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies
Highlights
The company's major contributor to revenue growth during 2002-2006 was product sales which increased at an absolute growth of +$689 million during the period
During fiscal 2006, the company generated approximately 90.3% of total revenues from product sales. Sales of Thalomid were $433 million during the year whereas Revlimid provided $321 million contributing collectively 84% of the total revenues in 2006
Celgene's biggest contributor to sales growth out to 2010 will be revenues from Revlimid sales. This is mainly due to the expectation that Revlimid will eventually become the most preferred therapy for multiple myeloma
Reasons to Purchase
Access all the important information and analysis on a company in a single report Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company's adjusted five year financial data along with key ratios and market capitalization
Scope
Highlights
Reasons to Purchase
Purchase Information
There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses RBSWorldpay.
Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Orders that are deliverable via email which are taken outside of working hours will be delivered next business day.
Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.
